Market Overview:
The global prostate biopsy devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of prostate cancer, technological advancements in prostate biopsy devices, and rising demand for minimally invasive procedures. Based on type, the global prostate biopsy devices market is segmented into reusable devices and disposable devices. The disposable device segment is expected to grow at a higher CAGR than the reusable device segment during the forecast period from 2018 to 2030. This can be attributed to factors such as ease of use and disposal, lower cost of disposable devices as compared with reusable ones, and growing preference for minimally invasive procedures over traditional surgical procedures. Based on application, the global prostate biopsy Devices market is divided into hospitals, ambulatory surgical centers (ASCs), and diagnostic centers. The hospitals segment dominates this market owing to high patient footfall in these institutions coupled with rising prevalence of cancer worldwide.
Product Definition:
A prostate biopsy device is a medical tool used to extract tissue samples from the prostate gland. This type of device can be inserted through the anus and into the rectum, or it may be inserted through a small incision in the lower abdomen.
Reusable Devices:
Reusable devices are instruments that are used more than once and can be categorized as a single-use device. The factors that propel the growth of this market include growing demand for minimally invasive procedures, increasing prevalence of prostate cancer, technological advancements in medical devices, rising disposable income levels in developing countries and government initiatives to reduce healthcare expenditure.
Disposable Devices:
Disposable devices are medical instruments that are intended for single use only and are designed in such a way that they can be safely disposed of after the completion of the desired surgical or diagnostic procedure. The global disposable devices and it’s usage in prostate biopsy devices market is expected to witness significant growth over the forecast period owing to factors such as increasing prevalence of various cancers, technological advancements, rising awareness about various types of cancer among people coupled with growing demand for minimally invasive surgeries.
Application Insights:
The hospitals application segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to a rise in prostate cancer cases, which require biopsy for diagnosis. Moreover, increasing awareness about early detection of this disease is further driving growth. According to a study published by NCBI, it has been found that around 1 out of 6 men aged between 50 and 74 years develop prostate cancer every year. Thus, an increasing number of patients requiring biopsy at hospitals is boosting demand for these devices globally.
Ambulatory surgical centers (ASCs) are anticipated to register the fastest CAGR during the forecast period owing to factors such as rising awareness among individuals regarding early detection of this disease coupled with improved treatment facilities at these centers.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of prostate cancer and favorable reimbursement policies. The U.S. is one of the most lucrative markets for medical devices, with over 8 million men suffering from prostate cancer at some point in their lives as compared to 6 million cases diagnosed annually (as per statistics released by American Cancer Society). Thus, an increase in incidence coupled with rising awareness levels among individuals is expected to drive regional growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period due to increasing disposable income and healthcare expenditure levels along with growing patient awareness regarding early diagnosis of life-threatening diseases such as prostate cancer which has become one of leading causes for all cause mortality among males aged 65 years & above (mortality rate ratio 1.8).
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for prostate biopsy devices as they are used for the diagnosis of prostate cancer.
- Growing awareness about early detection and treatment options: There is an increasing awareness among people about the benefits of early detection and treatment options for various diseases including prostate cancer. This will drive the demand for diagnostic devices such as prostate biopsy devices.
- Technological advancements in prostatic biopsy devices: There has been a significant advancement in prostatic biopsy device technology in recent years which has made these devices more accurate and efficient than ever before. This will lead to an increase in their adoption rates across hospitals and clinics worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prostate Biopsy Devices Market Research Report
By Type
Reusable Devices, Disposable Devices
By Application
Hospitals, Ambulatory Surgical Center (ASCs), Diagnostic Centers
By Companies
Bard, BD, Argon Medical Devices, Invivo, Cook Medical, TSK, UROMED, Biomedical, Sterylab, Amecath, Geotekmedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Prostate Biopsy Devices Market Report Segments:
The global Prostate Biopsy Devices market is segmented on the basis of:
Types
Reusable Devices, Disposable Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Center (ASCs), Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bard
- BD
- Argon Medical Devices
- Invivo
- Cook Medical
- TSK
- UROMED
- Biomedical
- Sterylab
- Amecath
- Geotekmedical
Highlights of The Prostate Biopsy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Devices
- Disposable Devices
- By Application:
- Hospitals
- Ambulatory Surgical Center (ASCs)
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prostate Biopsy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prostate biopsy devices is a medical device used to remove tissue from the prostate for examination.
Some of the major players in the prostate biopsy devices market are Bard, BD, Argon Medical Devices, Invivo, Cook Medical, TSK, UROMED, Biomedical, Sterylab, Amecath, Geotekmedical.
The prostate biopsy devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prostate Biopsy Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prostate Biopsy Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prostate Biopsy Devices Market - Supply Chain
4.5. Global Prostate Biopsy Devices Market Forecast
4.5.1. Prostate Biopsy Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prostate Biopsy Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prostate Biopsy Devices Market Absolute $ Opportunity
5. Global Prostate Biopsy Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prostate Biopsy Devices Market Size and Volume Forecast by Type
5.3.1. Reusable Devices
5.3.2. Disposable Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prostate Biopsy Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prostate Biopsy Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Center (ASCs)
6.3.3. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prostate Biopsy Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prostate Biopsy Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prostate Biopsy Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prostate Biopsy Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prostate Biopsy Devices Demand Share Forecast, 2019-2026
9. North America Prostate Biopsy Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prostate Biopsy Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prostate Biopsy Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Center (ASCs)
9.4.3. Diagnostic Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prostate Biopsy Devices Market Size and Volume Forecast by Type
9.7.1. Reusable Devices
9.7.2. Disposable Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prostate Biopsy Devices Demand Share Forecast, 2019-2026
10. Latin America Prostate Biopsy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prostate Biopsy Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prostate Biopsy Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Center (ASCs)
10.4.3. Diagnostic Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prostate Biopsy Devices Market Size and Volume Forecast by Type
10.7.1. Reusable Devices
10.7.2. Disposable Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prostate Biopsy Devices Demand Share Forecast, 2019-2026
11. Europe Prostate Biopsy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prostate Biopsy Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prostate Biopsy Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Center (ASCs)
11.4.3. Diagnostic Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prostate Biopsy Devices Market Size and Volume Forecast by Type
11.7.1. Reusable Devices
11.7.2. Disposable Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prostate Biopsy Devices Demand Share, 2019-2026
12. Asia Pacific Prostate Biopsy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prostate Biopsy Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prostate Biopsy Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Center (ASCs)
12.4.3. Diagnostic Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prostate Biopsy Devices Market Size and Volume Forecast by Type
12.7.1. Reusable Devices
12.7.2. Disposable Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prostate Biopsy Devices Demand Share, 2019-2026
13. Middle East & Africa Prostate Biopsy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prostate Biopsy Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prostate Biopsy Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Center (ASCs)
13.4.3. Diagnostic Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prostate Biopsy Devices Market Size and Volume Forecast by Type
13.7.1. Reusable Devices
13.7.2. Disposable Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prostate Biopsy Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Prostate Biopsy Devices Market: Market Share Analysis
14.2. Prostate Biopsy Devices Distributors and Customers
14.3. Prostate Biopsy Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bard
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Argon Medical Devices
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Invivo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cook Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. TSK
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. UROMED
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biomedical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sterylab
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Amecath
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Geotekmedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
